Abstract Submission
Guidelines for Research:
• Contains a clear statement of the hypothesis, and explanation of robust methods, and the results and a brief discussion of their implications in the conclusion.
• Subject matter must contain original data
Research Abstract submission has the following constraints:
• Title - maximum 150 characters including spaces (Do not add 'Title' as sub-heading)
• The abstract body must consist of purpose, methods, results, conclusions
• Abstract body is limited to 2500 characters including spaces
• Past tense should be used, with no use of personal pronouns.
• Use of material/chemical/ pharmaceutical names are encouraged rather than
manufacturer's product names
• Commercial relationships must be fully disclosed.
Guidelines for Clinical case reports:
Case reports submitted should contribute to medical knowledge and must have educational value or highlight the need for a change in clinical practice or diagnostic/prognostic approaches. We will not consider reports on topics that have already been well characterized or where other, similar, cases have already been published.
We welcome well-described and novel reports of cases that include any unreported or unusual side effects or adverse interactions of medication, diseases. Presentations, diagnoses and/or management of new and emerging diseases, new findings of possible pathogenesis of a disease are also accepted. Case reports should include relevant positive and negative findings from history, examination, and investigation, and can include clinical photographs, provided these are accompanied by a statement that written consent to publish was obtained from the patient(s). Case reports should include an up-to-date review of all previous cases in the field.
Case report Abstract template:
The Abstract should not exceed 350 words. Do not cite references in the abstract. The abstract must include the following separate sections.
Background:
The Background section should explain the background to the case report or study, its aims, a summary of the existing literature.
Case presentation:
This section should include a description of the patient’s relevant demographic details, medical history, symptoms and signs, treatment or intervention, outcomes, and any other significant details.
Discussion and Conclusions:
This should discuss the relevant existing literature and should clearly state the main conclusions, including an explanation of their relevance or importance to the field.
List of Abbreviations:
If abbreviations are used in the text, they should be defined in the text at first use, and a list of abbreviations should be provided.
Keywords:
Three to ten keywords representing the main content of the article.